longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

LABT

LABT
----

LongbridgeAI

Lakewood-Amedex Soars Over 53% Amid Board Appointment

Movers Alert
May 1, 2026 at 01:39 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Lakewood-Amedex Biotherapeutics(LABT.US)现价 $4.088,当日 +53.68%,盘中震荡拉升,市值暂无数据。公司聚焦生物治疗领域,股价大涨与 Joseph Tucker 博士加入董事会相关。近期无其他重大消息,市场偏向短线资金驱动。

Lakewood-Amedex Biotherapeutics (LABT.US) trades at $4.088, up +53.68% intraday, with no disclosed market cap.

The company operates in the biotherapeutics sector. The sharp rise follows the appointment of Dr. Joseph Tucker to the board. No further significant news; momentum likely driven by speculative trading.

Login to unlock311characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Biotherapeutics

LABT.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--